Recombinant Human USP46 protein is a Human Full Length protein, in the 1 to 366 aa range, expressed in Escherichia coli, with >90% purity and suitable for SDS-PAGE, MS.
M G S S H H H H H H S S G L V P R G S H M G S M T V R N I A S I C N M G T N A S A L E K D I G P E Q F P I N E H Y F G L V N F G N T C Y C N S V L Q A L Y F C R P F R E N V L A Y K A Q Q K K K E N L L T C L A D L F H S I A T Q K K K V G V I P P K K F I S R L R K E N D L F D N Y M Q Q D A H E F L N Y L L N T I A D I L Q E E K K Q E K Q N G K L K N G N M N E P A E N N K P E L T W V H E I F Q G T L T N E T R C L N C E T V S S K D E D F L D L S V D V E Q N T S I T H C L R D F S N T E T L C S E Q K Y Y C E T C C S K Q E A Q K R M R V K K L P M I L A L H L K R F K Y M E Q L H R Y T K L S Y R V V F P L E L R L F N T S S D A V N L D R M Y D L V A V V V H C G S G P N R G H Y I T I V K S H G F W L L F D D D I V E K I D A Q A I E E F Y G L T S D I S K N S E S G Y I L F Y Q S R E
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application MS | Reactivity Reacts | Dilution info - | Notes - |
Deubiquitinating enzyme that plays a role in behavior, possibly by regulating GABA action. May act by mediating the deubiquitination of GAD1/GAD67 (By similarity). Has almost no deubiquitinating activity by itself and requires the interaction with WDR48 to have a high activity (PubMed:19075014, PubMed:26388029). Not involved in deubiquitination of monoubiquitinated FANCD2 (PubMed:19075014).
Ubiquitin carboxyl-terminal hydrolase 46, Deubiquitinating enzyme 46, Ubiquitin thioesterase 46, Ubiquitin-specific-processing protease 46, USP46
Recombinant Human USP46 protein is a Human Full Length protein, in the 1 to 366 aa range, expressed in Escherichia coli, with >90% purity and suitable for SDS-PAGE, MS.
pH: 8
Constituents: 10% Glycerol (glycerin, glycerine), 0.88% Sodium chloride, 0.32% Tris HCl, 0.02% (R*,R*)-1,4-Dimercaptobutan-2,3-diol
ab177681 is purified using conventional chromatography techniques.
Deubiquitinating enzyme that plays a role in behavior, possibly by regulating GABA action. May act by mediating the deubiquitination of GAD1/GAD67 (By similarity). Has almost no deubiquitinating activity by itself and requires the interaction with WDR48 to have a high activity (PubMed:19075014, PubMed:26388029). Not involved in deubiquitination of monoubiquitinated FANCD2 (PubMed:19075014).
Belongs to the peptidase C19 family. USP12/USP46 subfamily.
USP46 also known as Deubiquitinating enzyme 46 is an important player in the process of removing ubiquitin molecules from proteins. This enzyme belonging to the ubiquitin-specific protease family has a molecular mass of approximately 41 kDa. USP46 is widely expressed in various human tissues but significant levels are observed in the brain indicating its importance in neurological processes. Its deubiquitination activity modulate protein turn-over stability and signaling pathways influencing diverse cellular functions.
USP46 modulates the ubiquitin-proteasome system by removing ubiquitin from substrate proteins which impacts their degradation or activity. It exists as part of a larger protein complex interacting with proteins such as WDR20 which enhance its activity. This interaction allows USP46 to regulate protein homeostasis within neurons and other cells. In the nervous system its activity supports synaptic function and plasticity contributing to effective neural communication and cognitive processes.
USP46 mainly acts within the ubiquitin-proteasome pathway an essential mechanism for protein degradation and regulation. It interacts with proteins like UBE3A and UCH-L1 which are important for maintaining protein balance and cellular stress responses. Another important pathway involving USP46 is the neural plasticity and signaling pathway where it helps in regulating the degradation of synaptic proteins contributing to learning and memory.
USP46 has been linked to neurological disorders such as depression and schizophrenia. Abnormalities in its function or expression levels could disrupt normal synaptic activity and protein homeostasis. The enzyme shows a connection with proteins like GSK3β and DISC1 which are implicated in these disorders. Targeting USP46 activity holds potential in developing new therapeutic strategies for such neuro-psychiatric conditions offering avenues for further research and innovation in medical science.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com